常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
2.78/3.60
|
|
企业价值
123.96B
|
| 资产负债 |
|
每股账面净值
10.93
|
| 现金流量 |
|
现金流量率
0.09
|
| 损益表 |
|
收益
21.41B
|
|
每股收益
18.04
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV. |

55.51 
